MESA LABORATORIES INC /CO (MLAB) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
44/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseMLAB / S&P 12.76% / 15.20% |
LoseMLAB / S&P 3.04% / 15.00% |
LoseMLAB / S&P -753.85% / 50.40% |
| 2026-Q11/3 |
WinMLAB / S&P 12.83% / -4.33% |
LoseMLAB / S&P 3.38% / 11.30% |
LoseMLAB / S&P -436.11% / 27.70% |
| 2025-Q41/3 |
WinMLAB / S&P 17.38% / 2.65% |
LoseMLAB / S&P 4.12% / 9.00% |
LoseMLAB / S&P -101.40% / 13.40% |
| 2025-Q31/3 |
LoseMLAB / S&P -28.71% / 8.12% |
WinMLAB / S&P 7.39% / 4.61% |
LoseMLAB / S&P -99.32% / 13.45% |
| 2025-Q21/3 |
LoseMLAB / S&P -20.48% / 10.94% |
WinMLAB / S&P 8.33% / 4.83% |
LoseMLAB / S&P -99.72% / 10.63% |
| 2025-Q11/3 |
LoseMLAB / S&P -9.91% / -4.27% |
WinMLAB / S&P 11.47% / 4.98% |
LoseMLAB / S&P -99.24% / 10.57% |
| 2024-Q41/3 |
LoseMLAB / S&P 1.69% / 2.41% |
WinMLAB / S&P 11.68% / 5.25% |
LoseMLAB / S&P -27347.06% / 6.15% |
| 2024-Q33/3 |
WinMLAB / S&P 49.84% / 5.89% |
WinMLAB / S&P 6.88% / 5.89% |
WinMLAB / S&P 32485.71% / 6.11% |
| 2024-Q20/3 |
LoseMLAB / S&P -20.81% / 4.28% |
LoseMLAB / S&P 2.02% / 5.38% |
LoseMLAB / S&P -14184.85% / 5.12% |
| 2024-Q10/3 |
LoseMLAB / S&P 4.89% / 10.56% |
LoseMLAB / S&P -1.32% / 5.71% |
LoseMLAB / S&P -29600.00% / 5.59% |
| 2023-Q40/3 |
LoseMLAB / S&P -0.10% / 11.69% |
LoseMLAB / S&P -4.27% / 6.81% |
LoseMLAB / S&P -158.62% / 7.78% |
| 2023-Q30/3 |
LoseMLAB / S&P -18.14% / -3.27% |
LoseMLAB / S&P -4.08% / 7.52% |
LoseMLAB / S&P -81.58% / -5.03% |
| 2023-Q21/3 |
LoseMLAB / S&P -26.37% / 8.74% |
WinMLAB / S&P 9.71% / 9.50% |
LoseMLAB / S&P -210.00% / -8.57% |
| 2023-Q11/3 |
LoseMLAB / S&P 5.22% / 7.50% |
WinMLAB / S&P 18.85% / 10.77% |
LoseMLAB / S&P -54.29% / -15.69% |
| 2022-Q42/3 |
WinMLAB / S&P 18.13% / 7.56% |
WinMLAB / S&P 36.07% / 11.88% |
LoseMLAB / S&P -119.86% / -17.99% |
| 2022-Q31/3 |
LoseMLAB / S&P -30.88% / -4.88% |
WinMLAB / S&P 55.90% / 13.47% |
LoseMLAB / S&P -179.17% / -1.41% |
| 2022-Q21/3 |
LoseMLAB / S&P -19.93% / -16.10% |
WinMLAB / S&P 43.88% / 13.71% |
LoseMLAB / S&P -138.96% / 11.04% |
| 2022-Q11/3 |
LoseMLAB / S&P -22.27% / -4.60% |
WinMLAB / S&P 37.63% / 15.97% |
LoseMLAB / S&P -46.15% / 42.23% |
| 2021-Q41/3 |
LoseMLAB / S&P 8.57% / 11.03% |
WinMLAB / S&P 25.53% / 15.00% |
LoseMLAB / S&P -417.39% / 96.40% |
| 2021-Q32/3 |
WinMLAB / S&P 11.57% / 0.58% |
WinMLAB / S&P 11.93% / 10.77% |
LoseMLAB / S&P -260.00% / 69.42% |
| 2021-Q22/3 |
WinMLAB / S&P 11.44% / 8.55% |
WinMLAB / S&P 14.48% / 6.58% |
LoseMLAB / S&P -302.63% / 51.81% |
| 2021-Q12/3 |
LoseMLAB / S&P -15.00% / 6.17% |
WinMLAB / S&P 13.81% / -1.06% |
WinMLAB / S&P 32.65% / 7.39% |
| 2020-Q42/3 |
WinMLAB / S&P 12.58% / 12.15% |
WinMLAB / S&P 18.43% / -3.72% |
LoseMLAB / S&P -138.98% / -33.42% |
| 2020-Q32/3 |
WinMLAB / S&P 17.59% / 8.93% |
WinMLAB / S&P 21.64% / -2.04% |
LoseMLAB / S&P -124.79% / -27.10% |
| 2020-Q21/3 |
LoseMLAB / S&P -4.05% / 20.54% |
WinMLAB / S&P 16.36% / -0.46% |
LoseMLAB / S&P -119.59% / -27.11% |
| 2020-Q12/3 |
WinMLAB / S&P -9.29% / -19.60% |
WinMLAB / S&P 14.11% / 3.47% |
LoseMLAB / S&P -73.80% / -14.75% |
| 2019-Q41/3 |
LoseMLAB / S&P 4.96% / 9.07% |
WinMLAB / S&P 6.14% / 5.36% |
LoseMLAB / S&P -55.47% / 2.99% |
| 2019-Q30/3 |
LoseMLAB / S&P -2.62% / 1.70% |
LoseMLAB / S&P 4.37% / 5.02% |
LoseMLAB / S&P -593.88% / 0.21% |
| 2019-Q21/3 |
WinMLAB / S&P 6.07% / 4.30% |
LoseMLAB / S&P 5.71% / 6.64% |
LoseMLAB / S&P -1485.71% / 8.65% |
| 2019-Q10/3 |
LoseMLAB / S&P 10.69% / 13.65% |
LoseMLAB / S&P 7.23% / 8.12% |
LoseMLAB / S&P -330.86% / 14.29% |
| 2018-Q42/3 |
WinMLAB / S&P 12.35% / -13.52% |
WinMLAB / S&P 10.66% / 9.05% |
LoseMLAB / S&P -365.00% / 18.23% |
| 2018-Q30/3 |
LoseMLAB / S&P -11.99% / 7.71% |
LoseMLAB / S&P 7.24% / 10.21% |
LoseMLAB / S&P -117.69% / 19.06% |
| 2018-Q21/3 |
WinMLAB / S&P 42.34% / 3.43% |
LoseMLAB / S&P 3.60% / 9.03% |
LoseMLAB / S&P -105.02% / 14.46% |
| 2018-Q11/3 |
WinMLAB / S&P 19.56% / -0.76% |
LoseMLAB / S&P 2.68% / 7.68% |
LoseMLAB / S&P -127.84% / 12.46% |
| 2017-Q40/3 |
LoseMLAB / S&P -16.66% / 6.64% |
LoseMLAB / S&P -0.62% / 7.03% |
LoseMLAB / S&P -133.00% / 13.82% |
| 2017-Q30/3 |
LoseMLAB / S&P 4.32% / 4.48% |
LoseMLAB / S&P 3.90% / 5.68% |
LoseMLAB / S&P -3.82% / 17.57% |
| 2017-Q22/3 |
WinMLAB / S&P 16.92% / 3.09% |
WinMLAB / S&P 8.68% / 4.83% |
LoseMLAB / S&P 1.82% / 17.74% |
| 2017-Q11/3 |
LoseMLAB / S&P 0.09% / 6.07% |
WinMLAB / S&P 10.64% / 3.67% |
LoseMLAB / S&P -2.02% / 13.32% |
| 2016-Q43/3 |
WinMLAB / S&P 7.47% / 3.82% |
WinMLAB / S&P 20.11% / 2.09% |
WinMLAB / S&P 19.76% / 7.05% |
| 2016-Q32/3 |
LoseMLAB / S&P -6.89% / 3.85% |
WinMLAB / S&P 18.24% / 0.20% |
WinMLAB / S&P 15.20% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MLAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 90.88% | 20.78% |
| Annualized return | 90.88% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MLAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -50.96% | 83.14% |
| Annualized return | -13.28% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | MLAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 18.25% | 319.30% |
| Annualized return | 1.69% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | United States | $0.546B | -2.74 |
| HURCO COMPANIES INC (HURC) | United States | $0.140B | -20.39 |
| SYPRIS SOLUTIONS INC (SYPR) | United States | $0.040B | -4.94 |
| ClearSign Technologies Corp (CLIR) | United States | $0.024B | -4.54 |
| FOCUS UNIVERSAL INC. (FCUV) | United States | $0.003B | -0.58 |
| Sensata Technologies Holding plc (ST) | $5.976B | 77.15 | |
| Ralliant Corp (RAL) | United States | $7.737B | -6.14 |
| COGNEX CORP (CGNX) | United States | $9.711B | 65.26 |
| Fortive Corp (FTV) | United States | $16.897B | 31.51 |
| MKS INC (MKSI) | United States | $17.440B | 68.37 |